Key Market Indicators
Sales of Swedish digestive system disorder medicine is set to reach $660 million by 2026, up from $615 million in 2021. That's a year-on-year growth rate of 1.1 percent. Since 2005, the Swedish market has grown at an average rate of 3.7 percent a year. In 2021, Sweden was ranked 14th in the world in terms of sales. Chile had the highest sales total, at $615 million. Japan, South Korea and Canada were the next three leading countries.
